Source:http://linkedlifedata.com/resource/pubmed/id/21522460
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 3
|
pubmed:dateCreated |
2011-4-27
|
pubmed:abstractText |
The crystal structure of the title compound, C(28)H(38)O(11), solved and refined against synchrotron diffraction data, contains two formula units in the asymmetric unit. In both mol-ecules, the dihydro-pyran ring along with its methyl substituents is disordered and adopts two alternative half-chair conformations. The occupancy of the major conformers of the two mol-ecules refined to 0.858?(5) and 0.523?(5).
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/21522460-10799717,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21522460-12714773,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21522460-17561088,
http://linkedlifedata.com/resource/pubmed/commentcorrection/21522460-18156677
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
1600-5368
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
o718
|
pubmed:dateRevised |
2011-11-11
|
pubmed:year |
2011
|
pubmed:articleTitle |
2,2,5,7,8-Penta-methyl-chroman-6-yl 2,3,4,6-tetra-O-acetyl-?-d-glucopyran-oside from synchrotron data.
|
pubmed:publicationType |
Journal Article
|